<SEC-DOCUMENT>0001965301-23-000027.txt : 20230530
<SEC-HEADER>0001965301-23-000027.hdr.sgml : 20230530
<ACCEPTANCE-DATETIME>20230530163408
ACCESSION NUMBER:		0001965301-23-000027
CONFORMED SUBMISSION TYPE:	144
PUBLIC DOCUMENT COUNT:		1
FILED AS OF DATE:		20230530
DATE AS OF CHANGE:		20230530

SUBJECT COMPANY:	

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Roivant Sciences Ltd.
		CENTRAL INDEX KEY:			0001635088
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				981173944
		STATE OF INCORPORATION:			D0
		FISCAL YEAR END:			0331

	FILING VALUES:
		FORM TYPE:		144
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	001-40782
		FILM NUMBER:		23977010

	BUSINESS ADDRESS:	
		STREET 1:		CLARENDON HOUSE, 2 CHURCH STREET
		CITY:			HAMILTON HM11
		STATE:			D0
		ZIP:			HM11
		BUSINESS PHONE:		441-295-5950

	MAIL ADDRESS:	
		STREET 1:		CLARENDON HOUSE
		STREET 2:		2 CHURCH STREET
		CITY:			HAMILTON
		STATE:			D0
		ZIP:			HM11

REPORTING-OWNER:	

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Ramaswamy Vivek
		CENTRAL INDEX KEY:			0001635075

	FILING VALUES:
		FORM TYPE:		144

	MAIL ADDRESS:	
		STREET 1:		C/O ONCORE BIOPHARMA, INC.
		STREET 2:		3805 OLD EASTON ROAD
		CITY:			DOYLESTOWN
		STATE:			PA
		ZIP:			18902

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Ramasawamy Vivek
		DATE OF NAME CHANGE:	20150226
</SEC-HEADER>
<DOCUMENT>
<TYPE>144
<SEQUENCE>1
<FILENAME>primary_doc.xml
<TEXT>
<XML>
<?xml version="1.0" encoding="UTF-8"?><edgarSubmission xmlns="http://www.sec.gov/edgar/ownership" xmlns:com="http://www.sec.gov/edgar/common">
  <headerData>
    <submissionType>144</submissionType>
    <filerInfo>
      <filer>
        <filerCredentials>
          <cik>0001635075</cik>
          <ccc>XXXXXXXX</ccc>
        </filerCredentials>
      </filer>
      <liveTestFlag>LIVE</liveTestFlag>


    </filerInfo>
  </headerData>
  <formData>
    <issuerInfo>
      <issuerCik>0001635088</issuerCik>
      <issuerName>Roivant Sciences LTD</issuerName>
      <secFileNumber>001-40782</secFileNumber>
      <issuerAddress>
        <com:street1>C/o Roivant 7th floor</com:street1>
        <com:street2>50 Broadway</com:street2>
        <com:city>London</com:city>
        <com:stateOrCountry>X0</com:stateOrCountry>
        <com:zipCode>SW1H 0DB</com:zipCode>
      </issuerAddress>
      <issuerContactPhone>44207 400 3347</issuerContactPhone>
      <nameOfPersonForWhoseAccountTheSecuritiesAreToBeSold>Ramaswamy Vivek</nameOfPersonForWhoseAccountTheSecuritiesAreToBeSold>
      <relationshipsToIssuer>
        <relationshipToIssuer>10% Stockholder</relationshipToIssuer>
      </relationshipsToIssuer>
    </issuerInfo>
    <securitiesInformation>
      <securitiesClassTitle>common</securitiesClassTitle>
      <brokerOrMarketmakerDetails>
        <name>Rockefeller Financial LLC</name>
        <address>
          <com:street1>45 Rockefeller Plaza - Floor 5</com:street1>
          <com:city>New York</com:city>
          <com:stateOrCountry>NY</com:stateOrCountry>
          <com:zipCode>10111</com:zipCode>
        </address>
      </brokerOrMarketmakerDetails>
      <noOfUnitsSold>382203</noOfUnitsSold>
      <aggregateMarketValue>355830993.00</aggregateMarketValue>
      <noOfUnitsOutstanding>758427350</noOfUnitsOutstanding>
      <approxSaleDate>05/30/2023</approxSaleDate>
      <securitiesExchangeName>NASDAQ</securitiesExchangeName>
    </securitiesInformation>
    <securitiesToBeSold>
      <securitiesClassTitle>Common</securitiesClassTitle>
      <acquiredDate>05/27/2023</acquiredDate>
      <natureOfAcquisitionTransaction>Capped Value Appreciation Rights granted under the Roivant Sciences Ltd. Amended and Restated 2015 Equity Incentive Plan</natureOfAcquisitionTransaction>
      <nameOfPersonfromWhomAcquired>Roivant Sciences Ltd.</nameOfPersonfromWhomAcquired>
      <isGiftTransaction>N</isGiftTransaction>
      <amountOfSecuritiesAcquired>382203</amountOfSecuritiesAcquired>
      <paymentDate>05/27/2023</paymentDate>
      <natureOfPayment>N/A</natureOfPayment>
    </securitiesToBeSold>
    <nothingToReportFlagOnSecuritiesSoldInPast3Months>Y</nothingToReportFlagOnSecuritiesSoldInPast3Months>
    <noticeSignature>
      <noticeDate>05/30/2023</noticeDate>
      <planAdoptionDates>
        <planAdoptionDate>02/23/2023</planAdoptionDate>
      </planAdoptionDates>
      <signature>Jason Coleman as a duly authorized representative of National Financial Services LLC, as attorney-in-fact for Vivek Ramaswamy</signature>
    </noticeSignature>
  </formData>
</edgarSubmission>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
